Eris Lifesciences Limited
NSE:ERIS.NS
1459 (INR) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 941.4 | 560.22 | 507.94 | 368.7 | 672.11 | 75 | 106.08 | 24.21 | 88.68 | 57.21 | 72.85 | 48.97 |
| Short Term Investments
| 0.02 | 332.21 | 1,264.47 | 153.99 | 747.81 | 3,149.42 | 937.89 | 2,584.83 | 653.2 | 692.4 | 669.64 | 465 |
| Cash and Short Term Investments
| 13,388.5 | 892.43 | 1,772.41 | 522.69 | 1,419.92 | 3,224.42 | 1,043.97 | 2,609.04 | 741.88 | 749.61 | 742.49 | 513.97 |
| Net Receivables
| 4,220.24 | 2,927.09 | 1,609.68 | 1,404.88 | 1,568.84 | 839.76 | 666.42 | 634.87 | 253.7 | 236.66 | 223.4 | 165.96 |
| Inventory
| 1,890.32 | 1,314.35 | 1,179.11 | 944.66 | 694.75 | 826.53 | 654.48 | 558.2 | 476.21 | 576.05 | 448.11 | 431.98 |
| Other Current Assets
| 3,521.67 | 2,545.49 | 1,361.34 | 1,035 | 1,111.7 | 927.08 | 622.5 | 188.43 | 121.11 | 72.46 | 140.78 | 317.6 |
| Total Current Assets
| 23,020.73 | 7,647.22 | 6,273.3 | 4,670.46 | 4,796.17 | 5,817.79 | 2,987.07 | 3,844.77 | 1,592.9 | 1,634.78 | 1,554.78 | 1,263.55 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 5,341.72 | 3,773.79 | 1,918.57 | 778.78 | 872.43 | 560.71 | 526.12 | 553.86 | 706.66 | 674.99 | 710.51 | 235.17 |
| Goodwill
| 8,612.13 | 3,318.49 | 934.74 | 934.74 | 934.74 | 935.87 | 1,869.48 | 792.61 | 0 | 35.53 | 32.16 | 32.84 |
| Intangible Assets
| 29,623.25 | 18,805.96 | 6,595.98 | 6,840.76 | 6,984.69 | 6,136.08 | 6,250.07 | 363.34 | 6.95 | 6.9 | 6.58 | 0.82 |
| Goodwill and Intangible Assets
| 38,235.38 | 22,124.45 | 7,530.72 | 7,775.5 | 7,919.43 | 7,071.95 | 8,119.55 | 1,155.95 | 6.95 | 42.43 | 38.74 | 33.66 |
| Long Term Investments
| 157.27 | 68.77 | 4,208.44 | 2,859.15 | 32.04 | 409.12 | 1,778.21 | -2,483.86 | 890.34 | 280.37 | -499.62 | -464.93 |
| Tax Assets
| 3,069.41 | 2,739.45 | 2,431.34 | 2,006.32 | 1,709.11 | 1,447.94 | 1,005.67 | 95.15 | 186.92 | 33.09 | 2.14 | 2.62 |
| Other Non-Current Assets
| 663.86 | 319.6 | 359.02 | 257.59 | 193.87 | 229.11 | 184.23 | 3,244.1 | 802.01 | 907.19 | 899.44 | 647.98 |
| Total Non-Current Assets
| 47,467.64 | 29,026.06 | 16,448.09 | 13,677.34 | 10,726.88 | 9,718.83 | 11,613.78 | 2,565.2 | 2,592.88 | 1,938.07 | 1,151.21 | 454.5 |
| Total Assets
| 70,488.37 | 36,673.28 | 22,721.39 | 18,347.8 | 15,523.05 | 15,536.62 | 14,600.85 | 6,409.97 | 4,185.78 | 3,572.85 | 2,705.99 | 1,718.05 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 2,683.48 | 1,247.69 | 1,177.74 | 1,026.16 | 1,000.51 | 841.25 | 907.74 | 0 | 0 | 367.11 | 373.83 | 220.17 |
| Short Term Debt
| 20,897.43 | 2,084.01 | 132.72 | 23.3 | -34.83 | 1,761.3 | 1,026.04 | 69.16 | 5 | -194.27 | -142.64 | 62.2 |
| Tax Payables
| 395.9 | 39 | 69.97 | 77.51 | 69.98 | 18.11 | 25.57 | 22.85 | 170.48 | 0 | 0 | 0 |
| Deferred Revenue
| 209.3 | 1,034.52 | 626.22 | 487.39 | 424.32 | 271.41 | 20.97 | 241.76 | 3.42 | 222.83 | 222 | 128.74 |
| Other Current Liabilities
| 1,134.66 | 1,028.28 | 577.32 | 513.41 | 491.58 | 408.55 | 274.28 | 730.29 | 514.03 | 40.21 | 41.27 | 24.45 |
| Total Current Liabilities
| 25,320.77 | 4,432.33 | 1,996.46 | 1,669.31 | 1,646.9 | 3,055.37 | 2,254.6 | 758.19 | 689.51 | 658.71 | 716.46 | 435.56 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 6,915.26 | 6,834.21 | 803.94 | 44.47 | 61.44 | 2.93 | 2,741.95 | 4.94 | 0 | 5 | 0 | 5.63 |
| Deferred Revenue Non-Current
| 13.84 | 87.39 | 56.88 | 61.11 | 85.45 | 66.63 | 209.72 | 10.78 | 0 | 5.63 | 2.99 | 0.81 |
| Deferred Tax Liabilities Non-Current
| 5,428.18 | 2,576.38 | 460.94 | 495.38 | 506.15 | 516.95 | 522.7 | 211.53 | 0 | 199.87 | 0 | 152.33 |
| Other Non-Current Liabilities
| 590.01 | 536.2 | 321.14 | 313.3 | 314.15 | 206.45 | 221.88 | 594.13 | 255.83 | 13.37 | 180.94 | 16.2 |
| Total Non-Current Liabilities
| 12,947.29 | 10,034.18 | 1,642.9 | 914.26 | 912.81 | 792.98 | 3,486.53 | 252.54 | 255.83 | 218.24 | 180.94 | 174.16 |
| Total Liabilities
| 38,268.06 | 14,466.51 | 3,639.36 | 2,583.57 | 2,559.71 | 3,848.35 | 5,741.13 | 1,010.73 | 945.34 | 876.95 | 897.4 | 609.72 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 21,930.12 | 19,062.41 | 15,722.73 | 13,590.85 | 12,056.17 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 136.03 | 135.99 | 135.93 | 135.78 | 135.78 | 137.5 | 137.5 | 137.5 | 1.38 | 1.38 | 1.38 | 1.38 |
| Retained Earnings
| 25,408.75 | 21,559.3 | 18,736.53 | 15,503.13 | 12,797.28 | 11,335.22 | 8,468.57 | 5,254.74 | 3,200.04 | 2,648.28 | 1,756.66 | 1,052.47 |
| Accumulated Other Comprehensive Income/Loss
| 135.7 | 29.76 | 20.7 | 41.48 | -711.33 | -543.99 | -389.87 | -619.96 | 7 | -315.35 | -163.28 | -118.04 |
| Other Total Stockholders Equity
| 180.71 | 151.01 | 106.13 | -15,722.73 | -12,849.24 | 13.49 | 0 | -7 | 0 | -7 | -7 | -7 |
| Total Shareholders Equity
| 25,861.19 | 21,959.88 | 19,083.11 | 15,764.21 | 12,963.34 | 11,505.16 | 8,613.07 | 5,399.24 | 3,208.42 | 2,656.66 | 1,765.04 | 1,060.85 |
| Total Equity
| 32,220.31 | 22,206.77 | 19,082.03 | 15,764.23 | 12,963.34 | 11,688.27 | 8,859.72 | 5,637.17 | 3,240.44 | 2,695.9 | 1,808.59 | 1,108.33 |
| Total Liabilities & Shareholders Equity
| 70,488.37 | 36,673.28 | 22,721.39 | 18,347.8 | 15,523.05 | 15,536.62 | 14,600.85 | 6,409.97 | 4,185.78 | 3,572.85 | 2,705.99 | 1,718.05 |